Fusion genes as biomarkers in pediatric cancers: A review of the current state and applicability in diagnostics and personalized therapy.

[1]  M. Boermeester,et al.  Clinical significance of translocation. , 1994, Gut.

[2]  K. Stegmaier,et al.  Targeted therapy for fusion-driven high-risk acute leukemia. , 2018, Blood.

[3]  Nicole Dastugue,et al.  Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Li Ding,et al.  The Pediatric Cancer Genome Project , 2012, Nature Genetics.

[5]  S. Lessnick,et al.  EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma. , 2009, Cancer research.

[6]  Keval Patel,et al.  Enhanced detection of circulating tumor DNA by fragment size analysis , 2018, Science Translational Medicine.

[7]  J. Cools,et al.  The genetics and molecular biology of T-ALL. , 2017, Blood.

[8]  Valeria R Smith,et al.  High-Risk Neuroblastoma Treatment Review , 2018, Children.

[9]  Pui-Yan Kwok,et al.  The genetics of splicing in neuroblastoma. , 2015, Cancer discovery.

[10]  S. Preston‐Martin,et al.  Trends in childhood brain tumor incidence, 1973–2009 , 2013, Journal of Neuro-Oncology.

[11]  R. Pieters,et al.  High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9 , 2006, Genes, chromosomes & cancer.

[12]  U. Dirksen,et al.  Ewing Sarcoma: Current Management and Future Approaches Through Collaboration. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  B. Hero,et al.  Neuroblastoma , 2007, The Lancet.

[14]  S. D. de Souza,et al.  A genomic case study of desmoplastic small round cell tumor: comprehensive analysis reveals insights into potential therapeutic targets and development of a monitoring tool for a rare and aggressive disease , 2016, Human Genomics.

[15]  Cheng Cheng,et al.  THE GENOMIC LANDSCAPE OF PEDIATRIC AND YOUNG ADULT T-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA , 2017, Nature Genetics.

[16]  J. Rowley.  A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.

[17]  G. Leverger,et al.  Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  B. Chabner,et al.  Application of Cell-free DNA Analysis to Cancer Treatment. , 2018, The New England journal of medicine.

[19]  C. Harrison.  Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia , 2009, British journal of haematology.

[20]  M. Meyerson,et al.  Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors. , 2018, JCO precision oncology.

[21]  M. Tress,et al.  Chimeras taking shape: Potential functions of proteins encoded by chimeric RNA transcripts , 2012, Genome research.

[22]  A. Llombart‐Bosch,et al.  Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis. , 2018, Annals of diagnostic pathology.

[23]  J. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. , 2019, Neuro-oncology.

[24]  C. Pui,et al.  Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. , 2000, The New England journal of medicine.

[25]  D. Ledbetter,et al.  Multicolor Spectral Karyotyping of Human Chromosomes , 1996, Science.

[26]  Medulloblastoma (?) , 1931 .

[27]  M. Valentine,et al.  Variant Translocations of Chromosome 13 in Alveolar Rhabdomyosarcoma , 1991, Genes, chromosomes & cancer.

[28]  C. Fisher,et al.  Mesenchymal Tumors with EWSR1 Gene Rearrangements. , 2019, Surgical pathology clinics.

[29]  E. Canaani,et al.  Fused transcript of abl and bcr genes in chronic myelogenous leukaemia , 1985, Nature.

[30]  C. Pui,et al.  The Promise and the Reality of Genomics to Guide Precision Medicine in Pediatric Oncology: The Decade Ahead , 2020, Clinical pharmacology and therapeutics.

[31]  C. Fletcher,et al.  Round cell sarcomas - biologically important refinements in subclassification. , 2014, The international journal of biochemistry & cell biology.

[32]  E. Lalli,et al.  DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells , 2008, Oncogene.

[33]  A. Viale,et al.  Plasma DNA-based molecular diagnosis, prognostication, and monitoring of patients with EWSR1 fusion-positive sarcomas. , 2017, JCO precision oncology.

[34]  C. Eckert,et al.  High sensitivity and clonal stability of the genomic fusion as single marker for response monitoring in ETV6‐RUNX1‐positive acute lymphoblastic leukemia , 2019, Pediatric blood & cancer.

[35]  N. Heerema,et al.  Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  Siobhan M. Phillips,et al.  Survivors of Childhood Cancer in the United States: Prevalence and Burden of Morbidity , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[37]  C. Larsson,et al.  Splicing-sensitive fusion transcripts associated with key tumor characteristics occur at high frequency in neuroblastoma , 2019, bioRxiv.

[38]  D. Johnston,et al.  Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group. , 2012, Blood.

[39]  Michael C. Heinold,et al.  The landscape of genomic alterations across childhood cancers , 2018, Nature.

[40]  R. Pieters,et al.  NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern. , 2011, Blood.

[41]  Michael A. Dyer,et al.  Neuroblastoma: developmental biology, cancer genomics and immunotherapy , 2013, Nature Reviews Cancer.

[42]  David M. Thomas,et al.  Diagnosis of fusion genes using targeted RNA sequencing , 2019, Nature Communications.

[43]  D. Jd,et al.  Pediatric AML: From Biology to Clinical Management , 2015 .

[44]  Lynette M. Smith,et al.  Genomic and clinical analysis of fusion gene amplification in rhabdomyosarcoma: A report from the Children's Oncology Group , 2012, Genes, chromosomes & cancer.

[45]  David T. W. Jones,et al.  Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations , 2012, Cell.

[46]  Xin Zhou,et al.  Pan-cancer genome and transcriptome analyses of 1,699 pediatric leukemias and solid tumors , 2018, Nature.

[47]  L. Foroni,et al.  Cytogenetics and molecular genetics of acute lymphoblastic leukemia. , 2002, Reviews in clinical and experimental hematology.

[48]  D. Reinhardt,et al.  Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012 , 2018, Leukemia.

[49]  M. Ladanyi,et al.  PRCC-TFE3 Renal Carcinomas: Morphologic, Immunohistochemical, Ultrastructural, and Molecular Analysis of an Entity Associated With the t(X;1)(p11.2;q21) , 2002, The American journal of surgical pathology.

[50]  M. Greaves,et al.  Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model , 2005, Oncogene.

[51]  L. Sekhar,et al.  Neurotrophic Receptor Tyrosine Kinase 2 (NTRK2) Alterations in Low-Grade Gliomas: Report of a Novel Gene Fusion Partner in a Pilocytic Astrocytoma and Review of the Literature , 2020, Case reports in pathology.

[52]  L. Gorunova,et al.  Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity? , 2015, Neuro-oncology.

[53]  Christopher B. Miller,et al.  BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros , 2008, Nature.

[54]  C. Pui,et al.  Somatic and germline genomics in paediatric acute lymphoblastic leukaemia , 2018, Nature Reviews Clinical Oncology.

[55]  Xiao Yang,et al.  Alignment-free filtering for cfNA fusion fragments , 2019, Bioinform..

[56]  T. Taki,et al.  A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial. , 2020, Blood.

[57]  Carlos Caldas,et al.  Analysis of circulating tumor DNA to monitor metastatic breast cancer. , 2013, The New England journal of medicine.

[58]  Benjamin J. Raphael,et al.  Expanding the computational toolbox for mining cancer genomes , 2014, Nature Reviews Genetics.

[59]  M. Ladanyi,et al.  Undifferentiated small round cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions. , 2007, The Journal of molecular diagnostics : JMD.

[60]  W. Gerald,et al.  EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[61]  L. Pachter,et al.  Fusion detection and quantification by pseudoalignment , 2017, bioRxiv.

[62]  S. Raimondi,et al.  Acute Myeloid Leukemia , 2020, The New England journal of medicine.

[63]  Hui Li,et al.  Gene fusions and chimeric RNAs, and their implications in cancer , 2019, Genes & diseases.

[64]  W. Kuo,et al.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.

[65]  Simona Soverini,et al.  Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. , 2006, Blood.

[66]  P. Sorensen,et al.  Ewing Sarcoma , 2020, Sarcomas.

[67]  Chittibabu Guda,et al.  Pan-Cancer Analysis Reveals the Diverse Landscape of Novel Sense and Antisense Fusion Transcripts , 2020, Molecular therapy. Nucleic acids.

[68]  K. Kinzler,et al.  Detection and quantification of rare mutations with massively parallel sequencing , 2011, Proceedings of the National Academy of Sciences.

[69]  G. Brodeur.  Neuroblastoma: biological insights into a clinical enigma , 2003, Nature Reviews Cancer.

[70]  Dean Nizetic,et al.  Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia , 2001, Nature Genetics.

[71]  Laising Yen,et al.  RNA-mediated gene fusion in mammalian cells , 2018, Proceedings of the National Academy of Sciences.

[72]  H. Weintraub,et al.  The helix-loop-helix gene E2A is required for B cell formation , 1994, Cell.

[73]  M. Stroun,et al.  Neoplastic characteristics of the DNA found in the plasma of cancer patients. , 1989, Oncology.

[74]  Roland Eils,et al.  The whole-genome landscape of medulloblastoma subtypes , 2017, Nature.

[75]  K. Ottersbach,et al.  Molecular processes involved in B cell acute lymphoblastic leukaemia , 2017, Cellular and Molecular Life Sciences.

[76]  M. Greaves,et al.  Chromosome translocations and covert leukemic clones are generated during normal fetal development , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[77]  G. Thomas,et al.  Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours , 1992, Nature.

[78]  C. Tournigand,et al.  Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary Carcinomas. , 2016, European urology.

[79]  M. Babu,et al.  Discovering and understanding oncogenic gene fusions through data intensive computational approaches , 2016, Nucleic acids research.

[80]  M. Mehta,et al.  Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[81]  R. Palmer,et al.  The role of the ALK receptor in cancer biology. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[82]  Funda Meric-Bernstam,et al.  Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children , 2018, The New England journal of medicine.

[83]  Nikhil Wagle,et al.  Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors , 2017, Nature Communications.

[84]  Steven J. M. Jones,et al.  The genetic landscape of high-risk neuroblastoma , 2013, Nature Genetics.

[85]  Ryan D. Morin,et al.  Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. , 2012, Cancer cell.

[86]  D. Rodeberg,et al.  Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group , 2019, Cancer medicine.

[87]  Heather L. Mulder,et al.  An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia. , 2012, Cancer cell.

[88]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[89]  C. Larsson,et al.  Alternative splicing in neuroblastoma generates RNA-fusion transcripts and is associated with vulnerability to spliceosome inhibitors , 2019 .

[90]  Elaine R. Mardis,et al.  Novel mutations target distinct subgroups of medulloblastoma , 2012, Nature.

[91]  J. Blay,et al.  SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma , 2020, The American journal of surgical pathology.

[92]  Emanuel J. V. Gonçalves,et al.  Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screening , 2019, Nature Communications.

[93]  Saijuan Chen,et al.  Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia , 2017, Proceedings of the National Academy of Sciences.

[94]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[95]  Mario Cazzola,et al.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.

[96]  B. Nadel,et al.  V(D)J-mediated Translocations in Lymphoid Neoplasms , 2002, The Journal of experimental medicine.

[97]  B. Johansson,et al.  The impact of translocations and gene fusions on cancer causation , 2007, Nature Reviews Cancer.

[98]  M. Teixeira,et al.  Recurrent fusion oncogenes in carcinomas. , 2006, Critical reviews in oncogenesis.

[99]  Ching-Hon Pui,et al.  Acute lymphoblastic leukemia. , 2004, The New England journal of medicine.

[100]  Adam Kiezun,et al.  Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma , 2014, Proceedings of the National Academy of Sciences.

[101]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[102]  M. Greaves,et al.  Origins of chromosome translocations in childhood leukaemia , 2003, Nature Reviews Cancer.

[103]  O. Delattre,et al.  Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma , 2017, Clinical Cancer Research.

[104]  C. Antonescu,et al.  Ewing sarcoma with FEV gene rearrangements is a rare subset with predilection for extraskeletal locations and aggressive behavior , 2019, Genes, chromosomes & cancer.

[105]  A. Cheung,et al.  Successful engraftment by leukemia initiating cells in adult acute lymphoblastic leukemia after direct intrahepatic injection into unconditioned newborn NOD/SCID mice. , 2010, Experimental hematology.

[106]  U. Dirksen,et al.  Risk of recurrence and survival after relapse in patients with Ewing sarcoma , 2011, Pediatric blood & cancer.

[107]  C. Mullighan.  Genomic characterization of childhood acute lymphoblastic leukemia. , 2013, Seminars in hematology.

[108]  T. Triche,et al.  Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[109]  R. Scolyer,et al.  Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti–Programmed Cell Death 1 Antibodies , 2018, JAMA oncology.

[110]  T. Caspersson,et al.  The 24 fluorescence patterns of the human metaphase chromosomes - distinguishing characters and variability. , 2009, Hereditas.

[111]  Elena Pereira,et al.  Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers , 2015, PloS one.

[112]  D. Gisselsson,et al.  Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma , 2012, Oncogene.

[113]  R. Sills,et al.  What Is Childhood Leukemia? , 2005 .

[114]  P. Brousset,et al.  Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study. , 2010, Blood.

[115]  M. Dowsett,et al.  Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer , 2015, Science Translational Medicine.

[116]  Li Ding,et al.  C11orf95-RELA fusions drive oncogenic NF-κB signaling in ependymoma , 2014, Nature.

[117]  Zev A. Binder,et al.  The Genetic Landscape of the Childhood Cancer Medulloblastoma , 2011, Science.

[118]  M. König,et al.  Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia , 2009, Leukemia.

[119]  J. Fujimoto,et al.  Prognostic model for predicting overall survival in children and adolescents with rhabdomyosarcoma , 2014, BMC Cancer.

[120]  O. Delattre,et al.  Superficial EWSR1-negative undifferentiated small round cell sarcoma with CIC/DUX4 gene fusion: a new variant of Ewing-like tumors with locoregional lymph node metastasis , 2013, Virchows Archiv.

[121]  L. Ries,et al.  Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. , 1999 .

[122]  S. Mortimer,et al.  The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients , 2017, Clinical Cancer Research.

[123]  C. Turc‐Carel,et al.  Consistent chromosomal translocation in alveolar rhabdomyosarcoma. , 1986, Cancer genetics and cytogenetics.

[124]  Z. Estrov,et al.  Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. , 1998, Blood.

[125]  B. Druker,et al.  Translation of the Philadelphia chromosome into therapy for CML. , 2008, Blood.

[126]  Hui Li,et al.  Intergenically Spliced Chimeric RNAs in Cancer. , 2016, Trends in cancer.

[127]  Roland Eils,et al.  Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma , 2013, Nature Genetics.

[128]  Li Ding,et al.  Driver Fusions and Their Implications in the Development and Treatment of Human Cancers , 2018, Cell reports.

[129]  Ahmedin Jemal,et al.  Childhood and adolescent cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[130]  M. Sanson,et al.  KIAA1549:BRAF fusion gene in pediatric brain tumors of various histogenesis , 2015, Pediatric blood & cancer.

[131]  M. Ladanyi,et al.  Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials. , 2020, The Lancet. Oncology.

[132]  O. Delattre,et al.  Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[133]  Eva Steliarova-Foucher,et al.  International incidence of childhood cancer, 2001–10: a population-based registry study , 2017, The Lancet. Oncology.

[134]  R. Baer.  TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia. , 1993, Seminars in cancer biology.

[135]  A. Green,et al.  The SCL Gene: From Case Report to Critical Hematopoietic Regulator , 1999 .

[136]  C. Antonescu,et al.  High prevalence of CIC fusion with double‐homeobox (DUX4) transcription factors in EWSR1‐negative undifferentiated small blue round cell sarcomas , 2012, Genes, chromosomes & cancer.

[137]  Yanjun Qi,et al.  Recurrent chimeric fusion RNAs in non-cancer tissues and cells , 2016, Nucleic acids research.

[138]  R. Doebele,et al.  TRKing down an old oncogene in a new era of targeted therapy. , 2015, Cancer discovery.

[139]  P. Sethupathy,et al.  Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma , 2017, Scientific Reports.

[140]  M. Busslinger,et al.  Pax5: the guardian of B cell identity and function , 2007, Nature Immunology.

[141]  P. Houghton,et al.  A specific chromosomal abnormality in rhabdomyosarcoma. , 1987, Cytogenetics and cell genetics.

[142]  G. Zon,et al.  Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells. , 1995, Blood.

[143]  B. Johansson,et al.  Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer , 2004, Nature Genetics.

[144]  Wei Zhang,et al.  Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment , 2013, Chinese journal of cancer.

[145]  F. Barr.  Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma , 2001, Oncogene.

[146]  Narasimhan P. Agaram,et al.  A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma: Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases , 2015, The American journal of surgical pathology.

[147]  Marco Beccuti,et al.  State of art fusion-finder algorithms are suitable to detect transcription-induced chimeras in normal tissues? , 2013, BMC Bioinformatics.

[148]  Leslie L Robison,et al.  Acute lymphoblastic leukaemia , 2018, Radiopaedia.org.

[149]  R. Foà,et al.  Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP). , 2009, Blood.

[150]  David T. W. Jones,et al.  Pilocytic astrocytoma: pathology, molecular mechanisms and markers , 2015, Acta Neuropathologica.

[151]  J. Nishio,et al.  A novel t(4;22)(q31;q12) produces an EWSR1–SMARCA5 fusion in extraskeletal Ewing sarcoma/primitive neuroectodermal tumor , 2011, Modern Pathology.

[152]  Gary D Bader,et al.  Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups. , 2015, Cancer cell.

[153]  Arul M. Chinnaiyan,et al.  Landscape of gene fusions in epithelial cancers: seq and ye shall find , 2015, Genome Medicine.

[154]  A. Sandberg,et al.  Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. , 2003, Cancer genetics and cytogenetics.

[155]  J. Downing,et al.  Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[156]  D. Miller,et al.  Identification of translocation chromosomes by quinacrine fluorescence. , 1972, American journal of diseases of children.

[157]  S. Jason,et al.  Neuroblastoma , 2018 .

[158]  P. Nowell,et al.  Chromosome studies in human leukemia. II. Chronic granulocytic leukemia. , 1961, Journal of the National Cancer Institute.

[159]  N. Darzentas,et al.  A Simple RNA Target Capture NGS Strategy for Fusion Genes Assessment in the Diagnostics of Pediatric B-cell Acute Lymphoblastic Leukemia , 2019, HemaSphere.

[160]  Li Ding,et al.  Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. , 2014, Cell reports.

[161]  J. Wolinsky,et al.  Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA , 2016, Cancer.

[162]  C. Croce,et al.  A novel zinc finger gene is fused to EWS in small round cell tumor , 2000, Oncogene.

[163]  N. Heerema,et al.  Biology and treatment of childhood T-lineage acute lymphoblastic leukemia. , 1998, Blood.

[164]  Jessica L. Davis,et al.  The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas , 2018, Cancer.

[165]  R. Doebele,et al.  Molecular Pathways Molecular Pathways : ROS 1 Fusion Proteins in Cancer , 2013 .

[166]  S. Korsmeyer,et al.  Defects in yolk sac hematopoiesis in Mll-null embryos. , 1997, Blood.

[167]  L. Sleire,et al.  Drug repurposing in cancer. , 2017, Pharmacological research.

[168]  E. V. Van Allen,et al.  Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group , 2018, British Journal of Cancer.

[169]  M. Hicks,et al.  Clinicopathologic features of osteosarcoma in patients with Rothmund-Thomson syndrome. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[170]  D. Sinnett,et al.  Molecular Profiling of Hard-to-Treat Childhood and Adolescent Cancers , 2019, JAMA network open.

[171]  J. Palis,et al.  Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. , 1999, Development.

[172]  A. Bruselles,et al.  Novel SEC61G-EGFR Fusion Gene in Pediatric Ependymomas Discovered by Clonal Expansion of Stem Cells in Absence of Exogenous Mitogens. , 2017, Cancer research.

[173]  R. Kaplan,et al.  New fusion sarcomas: histopathology and clinical significance of selected entities. , 2019, Human pathology.

[174]  C. Pui,et al.  Treatment of acute lymphoblastic leukemia. , 2006, The New England journal of medicine.

[175]  L. Hui,et al.  Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: A qualitative study. , 2016, Gene.

[176]  E. Perlman,et al.  Expanding the Spectrum of Renal Tumors in Children: Primary Renal Myoepithelial Carcinomas With a Novel EWSR1-KLF15 Fusion , 2016, The American journal of surgical pathology.

[177]  E. Yamaoka,et al.  Detection of MYCN amplification using blood plasma: noninvasive therapy evaluation and prediction of prognosis in neuroblastoma , 2013, Pediatric Surgery International.

[178]  J. Ban,et al.  Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells. , 2006, Cancer research.

[179]  P. Sorensen,et al.  Delayed early embryonic lethality following disruption of the murine cyclin A2 gene , 1999, Nature Genetics.

[180]  M. Slovak.  Cytogenetics of Acute Lymphoblastic Leukemia , 2014 .

[181]  A. Drilon,et al.  NTRK fusion-positive cancers and TRK inhibitor therapy , 2018, Nature Reviews Clinical Oncology.

[182]  Hui Li,et al.  Discovery of CTCF-Sensitive Cis-Spliced Fusion RNAs between Adjacent Genes in Human Prostate Cells , 2015, PLoS genetics.

[183]  T. Mok,et al.  Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy , 2015, Clinical Cancer Research.

[184]  S. Lessnick,et al.  GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance , 2009, Oncogene.

[185]  F. Barr,et al.  Therapeutic Approaches Targeting PAX3-FOXO1 and Its Regulatory and Transcriptional Pathways in Rhabdomyosarcoma , 2018, Molecules.

[186]  O. Williams,et al.  Mechanism of ETV6-RUNX1 Leukemia. , 2017, Advances in experimental medicine and biology.

[187]  J. Squire,et al.  Chromosomal instability in osteosarcoma and its association with centrosome abnormalities. , 2003, Cancer genetics and cytogenetics.

[188]  M. Tanimoto,et al.  Seven-year follow-up of patients receiving imatinib for the treatment of newly diagnosed chronic myelogenous leukemia by the TARGET system. , 2010, Leukemia research.

[189]  T. Taxter,et al.  FGFR3-TACC3 fusion in solid tumors: mini review , 2016, Oncotarget.

[190]  C. Mullighan.  Molecular genetics of B-precursor acute lymphoblastic leukemia. , 2012, The Journal of clinical investigation.

[191]  L. Helman,et al.  Pediatric soft tissue sarcomas , 1994, CA: a cancer journal for clinicians.

[192]  H. McDowell,et al.  Update on childhood rhabdomyosarcoma , 2003, Archives of disease in childhood.

[193]  Michael W. Bishop,et al.  The Cumulative Burden of Surviving Childhood Cancer: An Initial Report from the St. Jude Lifetime Cohort Study , 2017, The Lancet.

[194]  D. Chung,et al.  Pediatric solid malignancies: neuroblastoma and Wilms' tumor. , 2006, The Surgical clinics of North America.

[195]  T. Rabbitts,et al.  Chromosomal translocations in human cancer , 1994, Nature.

[196]  N. Smoll,et al.  The incidence of medulloblastomas and primitive neurectodermal tumours in adults and children , 2012, Journal of Clinical Neuroscience.

[197]  Ian Krop,et al.  E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements , 1994, Cell.

[198]  P. Campbell,et al.  Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations , 2015, Oncotarget.

[199]  Laurie Kurihara,et al.  ERASE-Seq: Leveraging replicate measurements to enhance ultralow frequency variant detection in NGS data , 2018, PloS one.

[200]  G. Thomas,et al.  A new member of the ETS family fused to EWS in Ewing tumors , 1997, Oncogene.

[201]  N. Konovalov,et al.  Molecular Biomarkers of Brain and Spinal Cord Astrocytomas , 2019, Acta naturae.

[202]  Kiran C. Bobba,et al.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.

[203]  Chittibabu Guda,et al.  ChimeRScope: a novel alignment-free algorithm for fusion transcript prediction using paired-end RNA-Seq data , 2017, Nucleic acids research.

[204]  K. Horibe,et al.  Discontinuation of l-asparaginase and poor response to prednisolone are associated with poor outcome of ETV6-RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemia , 2019, International Journal of Hematology.

[205]  Steven A. Roberts,et al.  Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .

[206]  U. Dirksen,et al.  Genomic EWSR1 Fusion Sequence as Highly Sensitive and Dynamic Plasma Tumor Marker in Ewing Sarcoma , 2016, Clinical Cancer Research.

[207]  B. Johansson,et al.  The emerging complexity of gene fusions in cancer , 2015, Nature Reviews Cancer.

[208]  M. Busslinger,et al.  Pax5: a master regulator of B cell development and leukemogenesis. , 2011, Advances in immunology.

[209]  I. Leuschner,et al.  Spindle Cell Variants of Embryonal Rhabdomyosarcoma in the Paratesticular Region: A Report of the Intergroup Rhabdomyosarcoma Study , 1993, The American journal of surgical pathology.

[210]  T. Merchant,et al.  Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas , 2012, Acta Neuropathologica.

[211]  Joshua L. Deignan,et al.  OncoKids: A Comprehensive Next-Generation Sequencing Panel for Pediatric Malignancies. , 2018, The Journal of molecular diagnostics : JMD.

[212]  M. Gerstung,et al.  Reliable detection of subclonal single-nucleotide variants in tumour cell populations , 2012, Nature Communications.

[213]  K. Horibe,et al.  Monitoring of fusion gene transcripts to predict relapse in pediatric acute myeloid leukemia , 2018, Pediatrics international : official journal of the Japan Pediatric Society.

[214]  T. Triche,et al.  The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts. , 1994, The New England journal of medicine.

[215]  C. Sarkar,et al.  C11orf95-RELA fusions and upregulated NF-KB signalling characterise a subset of aggressive supratentorial ependymomas that express L1CAM and nestin , 2018, Journal of Neuro-Oncology.

[216]  Eric W Prince,et al.  Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors , 2020, Pediatric blood & cancer.

[217]  Steven J. M. Jones,et al.  Subgroup-specific structural variation across 1,000 medulloblastoma genomes , 2012, Nature.

[218]  Xin Li,et al.  Short Homologous Sequences Are Strongly Associated with the Generation of Chimeric RNAs in Eukaryotes , 2008, Journal of Molecular Evolution.

[219]  P. Tan,et al.  Clear cell sarcomas of the kidney are characterised by BCOR gene abnormalities, including exon 15 internal tandem duplications and BCOR–CCNB3 gene fusion , 2018, Histopathology.